GlassScriptPhysician profile
Scott J Jarmain
NPI 1225017460
$2,637.15
in general payments reported to CMS, 2019-2025
24 companies · $746 in 2025
The $746 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $19.03 · 2022: $529 · 2023: $221 · 2024: $724 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,691.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $522.95 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Relievant Medsystems, INC. | $399.73 | 2022-2023 | Intracept |
| Nevro Corp. | $261.05 | 2019-2024 | Senza |
| Si-Bone, INC. | $197.67 | 2019-2025 | |
| 4web, INC. | $145.13 | 2024 | Spine Truss System |
| Boston Scientific Corporation | $142.50 | 2019-2025 | General - Pain Management, General - Therapies |
| Abbott Laboratories | $135.07 | 2023-2025 | Proclaim |
| Fidia Pharma USA INC. | $108.52 | 2019-2023 | Hymovis |
| Collegium Pharmaceutical, INC. | $104.24 | 2024-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $78.43 | 2025 | Senza, Vyrsa V1 |
| Saluda Medical Americas, INC. | $77.70 | 2025 | Evoke |
| Medtronic USA, INC. | $71.27 | 2019 | |
| Intrinsic Therapeutics | $58.26 | 2025 | Barricaid Acd (Annular Closure Device) |
| International Rehabilitative Sciences, INC | $48.92 | 2023-2024 | Rs 4i Plus Sequential Stimulator |
| Spr Therapeutics, INC | $48.67 | 2024-2025 | Sprint Pns System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $47.44 | 2025 | |
| Vertos Medical, INC. | $37.33 | 2023-2024 | Mild Device Kit |
| Ethicon US, LLC | $32.78 | 2019-2025 | Stratafix |
| Foundation Fusion Solutions, LLC | $31.85 | 2025 | |
| Painteq LLC | $28.39 | 2024 | Painteq |
| Vertex Pharmaceuticals Incorporated | $16.12 | 2024 | |
| Convatec INC. | $15.37 | 2024 | |
| Amgen INC. | $14.44 | 2019 | |
| Depuy Synthes Sales INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Jarmain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.